Dr. Joydeep Chakrabartty

Haemato Oncology

Oncology

HCG EKO Cancer Centre, Kolkata - Kolkata, India

Book Appointment

Visa Invitation Letter

Treatment Estimate

Qualification

MBBS, MRCP (UK), FRC PATH (UK), FRCP (Glasgow), CCT

Languages

English Hindi Bengali

Work Experience

20 Years

Research Experience

• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Dominique Farge*
Corinne Frere*
Jean M Connors
Cihan Ay
Alok A Khorana
Andres Munoz
Benjamin Brenner
Ajay Kakkar
Hanadi Rafii
Susan Solymoss
Dialina Brilhante
Manuel Monreal
Henri Bounameaux
Ingrid Pabinger
James Douketis
Joydeep Chakrabartty as a part of the International Initiative on Thrombosis and Cancer (ITAC) advisory panel; Lancet Oncol 2019; Published Online
September 3
2019 http: //dx.doi.org/10.1016/S1470-2045(19)30336-5
• Economic benefits of centrifugal method in therapeutic plasma exchange: experience from private hospitals in India- accepted for oral presentation- International Society of Apheresis
Kyoto
Japan
Oct 2019.
• Treosulfan based allogenic conditioning regimes including the use of Generic Treosulfan in Haematological malignancies – poster number 277
BMT Tandem meetings
2019

• Dikshit N
Sinha R
Maity H
et al. Dose escalation study of bendamustine based conditioning regime (Bace-bendamustine
cytarabine
cyclophosphamide and etoposide) in patients with lymphoma undergoing autologous stem cell transplant. Hematol Transfus Int J. 2017;5(5):294‒297.
• BMT TANDEM MEETING 2017(ASBMT) Bendamustine Based Conditioning Regime (BACE-Bendamustine
Cytarabine
Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing Autologous Stem Cell Transplant Jain
Neelesh
Amrita Chakrabarti
Rajani Sinha
Nitin Sood
Anil Arabandi
Kasturi Sengupta and Joydeep Chakrabartty
• BMT TANDEM MEETING 2017(ASBMT) Safety and efficacy of Darbapoietin alpha in minimizing transfusion requirements in autologous stem cell transplantation.
• Neelesh Jain
Amrita Chakrabarti
Rajani Sinha
Nitin Sood
Anil Arabandi
Kasturi Sengupta and Joydeep Chakrabartty Amrita Chakrabarti
Priyanka Samal
Joydeep Chakrabartty
Journal of Clinical and Diagnostic research
2016 Sep
Vol-10(9)
ED04-ED05.
• Bilateral combined Retinal Vascular Occlusion: An ocular presentation in Central Nervous System Re-relapse of Non Hodgkins Lymphoma
Amrita Chakrabarti
Priyanka Samal
Joydeep Chakrabartty
Opthalmology Research
5(4)
1-5
2016
article number-OR26848.
• A rare case of myelofibrosis secondary to juvenile idiopathic arthritis. Jain
N.
Sinha
R.
Sengupta
J. and Chakrabartty
J. British Journal of Haematology. doi: 10.1111/bjh.14106 Total Marrow Irradiation (TMI) Based T- Replete Myeloablative Haploidentical Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in Second Complete Remission: A Single Center Experience of Two Cases Jain
Neelesh
Amitabha Roy and Joydeep Chakrabartty; Biology of Blood and Marrow Transplant
Volume 22
Issue 3
S308
• Bendamustine Based Conditioning Regime (BACE-Bendamustine
Cytarabine
Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing.

Awards & Achivements

Academic Honors and Awards
• Gold Medalist
MBBS
University of Calcutta
India
• President's Gold Medal
MD (Pathology)
University of Calcutta
India
• Hunter Medal
MRCP (UK)
Royal College of Physicians
UK
• Outstanding Young Investigator Award
American Society of Hematology (ASH)
• Elected Fellow
Royal College of Pathologists (FRCPath)
UK
• Elected Fellow
Royal College of Physicians and Surgeons of Glasgow (FRCP)
UK
• Awarded D.Sc. (Honoris Causa) by University of Kalyani
India
Professional Recognition and Contributions
• Past President
Indian Society of Hematology and Blood Transfusion (ISHBT)
• Member of the Editorial Board
British Journal of Haematology
• Member of the Editorial Board
Blood Reviews
• Author of over 100 peer-reviewed publications in international journals
• Reviewer for numerous international journals
• Invited speaker at numerous international conferences
• Recipient of several research grants
Clinical Expertise and Contributions
• Renowned expert in the diagnosis and treatment of hematologic malignancies
including leukemia
lymphoma
and myeloma
• Pioneer in the development of new diagnostic and therapeutic strategies for hematologic malignancies
• Actively involved in clinical trials and research studies
• Dedicated to providing compassionate and personalized care to patients with hematologic malignancies
Dr. Chakrabartty is a highly respected and accomplished hematologist-oncologist who has made significant contributions to the field of hematology. He is a true pioneer in the field
and his work has helped to improve the lives of countless patients with hematologic malignancies.

Memberships

• Royal College of Physicians (RCP): The RCP is the professional organization for physicians in the United Kingdom. Dr. Chakrabartty is a Fellow of the RCP
which is the highest level of membership in the organization.
• Royal College of Pathologists (RCPath): The RCPath is the professional organization for pathologists in the United Kingdom. Dr. Chakrabartty is a Fellow of the RCPath
which is the highest level of membership in the organization.
• Faculty of Medicine of Glasgow (FMedG): The FMedG is the professional organization for physicians in Scotland. Dr. Chakrabartty is a Fellow of the FMedG
which is the highest level of membership in the organization.
• Indian Society of Hematology and Transfusion Medicine (ISHMT): The ISHMT is the professional organization for hematologists in India. Dr. Chakrabartty is a Life Member of the ISHMT
which is the highest level of membership in the organization.
• European Haematology Association (EHA): The EHA is the professional organization for hematologists in Europe. Dr. Chakrabartty is a Life Member of the EHA
which is the highest level of membership in the organization.
• American Society of Hematology (ASH): The ASH is the professional organization for hematologists in the United States. Dr. Chakrabartty is a Member of the ASH.
In addition to these professional memberships
Dr. Chakrabartty is also a member of several other organizations
including:
• Association of Radiation Oncologists of East India (AROEI)
• Bengal Oncology Society (BOS)
• Indian Medical Association (IMA)
Dr. Chakrabartty's memberships in these organizations demonstrate his commitment to the field of hematology and his dedication to providing his patients with the best possible care. He is a highly respected member of the hematology community
and he is making a significant contribution to the field.

Area of Interest

• Dr. Joydeep is skilled in the diagnosis
treatment and overall management of hematological disorders
such as leukemia
myeloma and other blood disorders.
• He is exceptionally skilled in critical care medicine too.
• Dr. Joydeep’s primary interest

Dr. Joydeep is an experienced haemato oncologist with over 20 years of experience in the diagnosis, treatment, and overall management of haematological disorders, such as leukaemia, myeloma, and other blood disorders. Dr. Joydeep’s primary interest lies in the areas of bone marrow transplantation (BMT), especially mismatched high-end transplants for all conditions, especially acute leukaemias. He is very competent in the laboratory diagnostic part of haematological diseases. He is exceptionally skilled in critical care medicine too.